Syntheses and biological evaluation of 18F-labeled 3-(1-benzyl-piperidin-4-yl)-1-(1-methyl-1H-indol-3-yl) propan-1-ones for in vivo mapping of acetylcholinesterase
Syntheses and biological evaluation of 18F-labeled 3-(1-benzyl-piperidin-4-yl)-1-(1-methyl-1H-indol-3-yl) propan-1-ones for in vivo mapping of acetylcholinesterase
复制标题
DOI:
10.1016/s0969-8051(00)00086-x
复制
发表时间:
2000-04-01
影响因子:
3.1
通讯作者:
Kim, BT
中科院分区:
文献类型:
--
作者:
Choe, YS;Oh, SJ;Kim, BT
We synthesized novel F-18-labeled acetylcholinesterase (AChE) inhibitors, 3-[1-(3- and 4-[F-18]fluoromethylbenzyl)piperidin-4-yl]-1-(1-methyl-1H-indol-3-yl)propan-1-ones ([F-18]1 and [F-18]2) and 3-[1-(4-[F-18]fluorobenzyl)piperidin-4-yl]-1-(1-methyl-1H-indol-3-yl)propan-1-one ([F-18]3) in high yields (decay-corrected, 25%-40%) and with high effective specific activities (>37 GBq/mu mol). Tissue distribution studies of the [F-18]1 and the [F-18]3 in mice showed the nonspecific bindings in brain regions, with metabolic defluorination of the [F-18]1. The result suggests that these radioligands may not be suitable agents for in vivo mapping of AChE, despite their potent in vitro anti-AChE activities. NUCL MED BIOL 27;3: 263-267, 2000. (C) 2000 Elsevier Science Inc. All rights reserved.